Biographies
Dr. Barry Ticho
Chief Medical Officer at Stoke Therapeutics

Dr. Barry Ticho is the Chief Medical Officer at Stoke Therapeutics

where he supports the development of first-in-class therapeutics to treat rare diseases.

Prior to joining Stoke, Barry was Head of Development of mRNA treatments for Cardiovascular and Metabolic Diseases at Moderna Therapeutics. Previously, he was Head of External R&D Innovation for Cardiovascular and Metabolic Diseases at Pfizer, and prior to that he was Vice President of Clinical Development at Biogen.

Barry obtained his M.D. and Ph.D. degrees from the University of Chicago and completed pediatrics training at Northwestern University and a cardiology fellowship at Children’s Hospital in Boston. He was on clinical staff at Harvard Medical School and Massachusetts General Hospital and conducted laboratory research on the regulation of cardiac development.

 

Twitter Feed